SCHEMBL5700901

SCHEMBL5700901

COC(=O)C[C@@H](NS(=O)(=O)c1cccnc1)c1ccc(N)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.47
SLC1A2 P43004 1/20 0.47
SLC1A1 P43005 1/20 0.47
KCNA5 P22460 8/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
KEAP1 Q14145 2/20 0.40
NFE2L2 Q16236 2/20 0.40
ITGAV P06756 2/20 0.40
ITGB3 P05106 1/20 0.40
ALDH1A1 P00352 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
EEF2K O00418 1/20 0.37
TBXAS1 P24557 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5700908 1.00 SLC1A3 (0.47) SLC1A3SLC1A2SLC1A1KCNA5SMN1; SMN2
SCHEMBL5700833 0.86 ALDH1A1 (0.52) SLC1A3SLC1A2SLC1A1KEAP1ITGAV
SCHEMBL5700825 0.86 ALDH1A1 (0.52) SLC1A3SLC1A2SLC1A1KEAP1ITGAV
SCHEMBL13418143 0.84 KCNA5 (0.45) SLC1A3SLC1A2SLC1A1KCNA5ITGAV
SCHEMBL5700886 0.77 MEN1 (0.48) KCNA5SMN1; SMN2ALDH1A1CYP3A4CYP2C9
SCHEMBL5700880 0.77 MEN1 (0.48) KCNA5SMN1; SMN2ALDH1A1CYP3A4CYP2C9
SCHEMBL27545824 0.72 SLC1A3 (0.51) SLC1A3SLC1A2SLC1A1ITGAVITGB3
SCHEMBL7400984 0.72 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1SMN1; SMN2KEAP1
SCHEMBL7400979 0.72 SLC1A3 (0.53) SLC1A3SLC1A2SLC1A1SMN1; SMN2KEAP1
SCHEMBL13418141 0.71 EEF2K (0.50) SLC1A3SLC1A2SLC1A1ITGAVITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1027328-B1 SUBSTITUTED ANILIDES AVENTIS PHARMA LTD (GB) 2006-08-23 EP disclosed
US-6479519-B1 INHIBITORS OF CELL ADHESION; TREATMENT OF ASTHMA OR INFLAMMATORY BOWEL DISEASE AVENTIS PHARMA LIMITED (GB) 2002-11-12 US disclosed